<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">467945314</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180405193736.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170328e20040101xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s00280-003-0704-y</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s00280-003-0704-y</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF02665358</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Fetal bovine serum, but not human serum, inhibits the in vitro cytotoxicity of ET-743 (Yondelis, trabectedin)</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="b">An example of potential problems for extrapolation of active drug concentrations from in vitro studies</subfield>
   <subfield code="c">[Gianluca Tognon, Roberta Frapolli, Marco Zaffaroni, Eugenio Erba, Massimo Zucchetti, Glynn Faircloth, Maurizio D'Incalci]</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer-Verlag, 2003</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Tognon</subfield>
   <subfield code="D">Gianluca</subfield>
   <subfield code="u">Department of Oncology, Istituto di Ricerche Farmacologiche &quot;Mario Negri”, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Frapolli</subfield>
   <subfield code="D">Roberta</subfield>
   <subfield code="u">Department of Oncology, Istituto di Ricerche Farmacologiche &quot;Mario Negri”, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Zaffaroni</subfield>
   <subfield code="D">Marco</subfield>
   <subfield code="u">Department of Oncology, Istituto di Ricerche Farmacologiche &quot;Mario Negri”, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Erba</subfield>
   <subfield code="D">Eugenio</subfield>
   <subfield code="u">Department of Oncology, Istituto di Ricerche Farmacologiche &quot;Mario Negri”, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Zucchetti</subfield>
   <subfield code="D">Massimo</subfield>
   <subfield code="u">Department of Oncology, Istituto di Ricerche Farmacologiche &quot;Mario Negri”, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Faircloth</subfield>
   <subfield code="D">Glynn</subfield>
   <subfield code="u">Pharma Mar USA, Inc., 320 Putnam Avenue, MA 02139-4616, Cambridge, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">D'Incalci</subfield>
   <subfield code="D">Maurizio</subfield>
   <subfield code="u">Department of Oncology, Istituto di Ricerche Farmacologiche &quot;Mario Negri”, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Cancer Chemotherapy and Pharmacology</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">53/1(2004-01-01), 89-90</subfield>
   <subfield code="x">0344-5704</subfield>
   <subfield code="q">53:1&lt;89</subfield>
   <subfield code="1">2004</subfield>
   <subfield code="2">53</subfield>
   <subfield code="o">280</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s00280-003-0704-y</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">brief-communication</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s00280-003-0704-y</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Faircloth</subfield>
   <subfield code="D">Glynn</subfield>
   <subfield code="u">Pharma Mar USA, Inc., 320 Putnam Avenue, MA 02139-4616, Cambridge, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Tognon</subfield>
   <subfield code="D">Gianluca</subfield>
   <subfield code="u">Department of Oncology, Istituto di Ricerche Farmacologiche &quot;Mario Negri”, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Frapolli</subfield>
   <subfield code="D">Roberta</subfield>
   <subfield code="u">Department of Oncology, Istituto di Ricerche Farmacologiche &quot;Mario Negri”, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Zaffaroni</subfield>
   <subfield code="D">Marco</subfield>
   <subfield code="u">Department of Oncology, Istituto di Ricerche Farmacologiche &quot;Mario Negri”, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Erba</subfield>
   <subfield code="D">Eugenio</subfield>
   <subfield code="u">Department of Oncology, Istituto di Ricerche Farmacologiche &quot;Mario Negri”, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Zucchetti</subfield>
   <subfield code="D">Massimo</subfield>
   <subfield code="u">Department of Oncology, Istituto di Ricerche Farmacologiche &quot;Mario Negri”, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">D'Incalci</subfield>
   <subfield code="D">Maurizio</subfield>
   <subfield code="u">Department of Oncology, Istituto di Ricerche Farmacologiche &quot;Mario Negri”, Milan, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Cancer Chemotherapy and Pharmacology</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">53/1(2004-01-01), 89-90</subfield>
   <subfield code="x">0344-5704</subfield>
   <subfield code="q">53:1&lt;89</subfield>
   <subfield code="1">2004</subfield>
   <subfield code="2">53</subfield>
   <subfield code="o">280</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF02665358</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Faircloth</subfield>
   <subfield code="D">Glynn</subfield>
   <subfield code="u">Pharma Mar USA, Inc., 320 Putnam Avenue, 02139-4616, Cambridge, MA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
